Inovio Pharmaceuticals Files 8-K
Ticker: INO · Form: 8-K · Filed: Jul 7, 2025 · CIK: 1055726
| Field | Detail |
|---|---|
| Company | Inovio Pharmaceuticals, INC. (INO) |
| Form Type | 8-K |
| Filed Date | Jul 7, 2025 |
| Risk Level | medium |
| Sentiment | neutral |
Sentiment: neutral
Topics: material-agreement, filing, corporate-event
Related Tickers: INO
TL;DR
INOVIO just filed an 8-K on 7/2/25 - big news incoming.
AI Summary
On July 2, 2025, Inovio Pharmaceuticals, Inc. entered into a material definitive agreement. The company also reported on other events and filed financial statements and exhibits. This filing is an 8-K, indicating a significant event for the company.
Why It Matters
This 8-K filing signals a material event for Inovio Pharmaceuticals, Inc., potentially impacting its stock and investor outlook.
Risk Assessment
Risk Level: medium — An 8-K filing indicates a material event, which could be positive or negative, thus carrying a medium risk level until details are fully understood.
Key Players & Entities
- INOVIO PHARMACEUTICALS, INC. (company) — Registrant
- July 2, 2025 (date) — Earliest event reported
- Delaware (jurisdiction) — State of incorporation
- 001-14888 (filing_id) — Commission File Number
- 33-0969592 (tax_id) — IRS Employer Identification No.
FAQ
What type of event triggered this 8-K filing?
The filing indicates an 'Entry into a Material Definitive Agreement' as a primary item, along with 'Other Events' and 'Financial Statements and Exhibits'.
When was the earliest event reported in this filing?
The earliest event reported was on July 2, 2025.
What is the company's state of incorporation?
The company is incorporated in Delaware.
What is the Commission File Number for Inovio Pharmaceuticals, Inc.?
The Commission File Number is 001-14888.
What is the IRS Employer Identification Number for the company?
The IRS Employer Identification Number is 33-0969592.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on July 7, 2025 regarding INOVIO PHARMACEUTICALS, INC. (INO).